Injectable Nanocomposite Implants Reduce ROS Accumulation and Improve Heart Function after Infarction

39Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In a myocardial infarction, blood supply to the left ventricle is abrogated due to blockage of one of the coronary arteries, leading to ischemia, which further triggers the generation of reactive oxygen species (ROS). These sequential processes eventually lead to the death of contractile cells and affect the integrity of blood vessels, resulting in the formation of scar tissue. A new heart therapy comprised of cardiac implants encapsulated within an injectable extracellular matrix-gold nanoparticle composite hydrogel is reported. The particles on the collagenous fibers within the hydrogel promote fast transfer of electrical signal between cardiac cells, leading to the functional assembly of the cardiac implants. The composite hydrogel is shown to absorb reactive oxygen species in vitro and in vivo in mice ischemia reperfusion model. The reduction in ROS levels preserve cardiac tissue morphology and blood vessel integrity, reduce the scar size and the inflammatory response, and significantly prevent the deterioration of heart function.

Cite

CITATION STYLE

APA

Shilo, M., Oved, H., Wertheim, L., Gal, I., Noor, N., Green, O., … Dvir, T. (2021). Injectable Nanocomposite Implants Reduce ROS Accumulation and Improve Heart Function after Infarction. Advanced Science, 8(24). https://doi.org/10.1002/advs.202102919

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free